Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2016 KRANKHEITSBILD NETZWERK REGISTRY PROJEKTE ANMELDEN
 
 
  
Experimental Rx -
--->Aktuelles
[-]Das Projekt
--->Sponsor
--->[+]Vorstand
--->[+]Writing Committee Strategic ...
--->[+]Wissenschaftl. Begutachtung
--->Zentrale Koordination
--->Länderkoordination
--->Fellowship Programme
--->[+]Constitution
--->[+]Voting/Nomination
--->[+]Mitglieder
[-]Standorte
--->[+]Österreich
--->[+]Belgien
--->[+]Tschechische Republik
--->[+]Dänemark
--->[+]Finnland
--->[+]Frankreich
--->[+]Deutschland
--->[+]Ireland
--->[+]Italien
--->[+]Niederlande
--->[+]Norwegen
--->[+]Polen
--->[+]Portugal
--->[+]Russia
--->[+]Spanien
--->[+]Schweden
--->[+]Schweiz
--->[-]U.K.
--->Koordination
--->Selbsthilfe
--->Links
--->[+]UKHDN
--->Standard of Care
--->Aberdeen
--->[+]Ayr
--->Belfast
--->Birmingham
--->[+]Blandford Forum
--->Bristol
--->Cambridge
--->Cardiff
--->Dundee
--->Edinburgh
--->Exeter
--->Fife
--->Forth Valley
--->Glasgow
--->Gloucester
--->Hull
--->Inverness
--->Launceston
--->Leeds
--->Leicester
--->Liverpool
--->London - Guy's Hospital
--->London - Hammersmith
--->London - NHNN
--->London - Royal Hospital
--->London St. George´s
--->Manchester
--->Newcastle-Upon-Tyne
--->[+]Northampton
--->Nottingham
--->Oxford
--->[+]Plymouth
--->Poole
--->Preston
--->Reading
--->[+]Sheffield
--->Southampton
--->Stoke-on-Trent
--->Swindon
--->Wrexham
--->[+]Outside Europe
[-]Arbeitsgruppen
--->[+]Advanced HD
--->[+]Psychiatrischer Phänotyp
--->[+]Biologische Modifizierer
--->[+]Biomarker
--->[-]Hirngewebedatenbank
--->[+]Termine
--->[+]Meetings
--->[+]Kognitiver Phänotyp
--->[+]Environmental Modifiers
--->[+]Funktionelle Fähigkeit
--->[+]Genetische Tests/Beratung
--->[+]Modifizierende Gene
--->[+]Gesundheitsökonomie
--->[+]Bildgebende Verfahren
--->[+]Juvenile HK
--->[+]Motorischer Phänotyp
--->[-]Neuroprotektive Therapie
--->[+]Termine
--->[+]Meetings
--->[+]Physiotherapie
--->[+]Lebensqualität
--->[+]Behandlungstandards
--->[+]Chirurgische Ansätze
--->[+]Symptomatische Therapie
--->[+]Young Adults
[-]Veranstaltungen
--->[-]EHDN 2016
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Floor plan
--->[+]Overduin Registration
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel booking
--->Social activities
--->Reimbursement
--->[+]Abstract Submission
--->Contacts
--->Documents
--->Feedback
--->EHDN 2014
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel Booking
--->Reimbursement
--->Social Activities
--->[+]Abstract Submission
--->Contacts
--->Feedback
--->[-]EHDN 2012
--->Introduction
--->Announcement
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Important Dates
--->Registration
--->[+]Travel & Accommodation
--->[+]EHA Registration
--->EHA Programme
--->Reception Dinner
--->About Stockholm
--->[+]Abstract Submission
--->Reimbursement
--->[-]Documents
--->Handouts
--->Presentations
--->[-]Posters
--->Pathogenic mechanisms
--->Animal models
--->Choreatic disorders - no...
--->Genetic modifiers
--->Wet Biomarkers
--->Imaging
--->Clin characteristics
--->Clin char-motor
--->Clin char-cognitive
--->Clin char - behaviour
--->Clin char-other
--->Clinical studies
--->Genetic testing
--->Clinical care
--->Experimental Rx
--->Clinical Rx
--->Non-scientific
--->Contacts
--->Feedback & Evaluation
--->[-]EHDN 2010
--->Introduction
--->Programme I
--->Programme II
--->Additional Meetings
--->Registration
--->EHA Programme
--->[+]EHA Registration
--->Plenary Dinner
--->Social Programme
--->Important Dates
--->[+]Abstract Submission
--->Reimbursement
--->Hotel Booking
--->[+]Travel and Location
--->[+]About Prague
--->Documents
--->Committees
--->Contact
--->Feedback & Evaluation
--->[-]EHDN 2008
--->Programme
--->Additional Meetings
--->EHA Programme
--->Social Programme
--->Kids Programme
--->Important Dates
--->Voting
--->Reimbursement
--->[+]Registration
--->[+]Abstract Submission
--->Evaluation & Feedback
--->[+]Travel and Location
--->[+]About Lisbon
--->[+]Documents
--->Committees
--->Contact
--->[+]EHDN 2007
--->[+]EHDN 2006
--->[-]EHDN 2005
--->Programm
--->Galadiner
--->Registrierung
--->Arbeitsgruppen
--->Tagungsort
--->Über Manchester
--->Evaluation & Feedback
--->[+]EHDN 2004
[+]Kommunikation
--->Stellenangebote
DatumBeschreibungGrößeAutor Dokument 
04.08.26In vivo efficacy of (CUG)n oligonucleotides to treat HD32 kBanonymousapplication/mswordp02-in-vivo-efficacy-oligonucleotides 
04.08.26Antisense oligonucleotide mediated transcript reduction and modulation – the European approach to develop a therapy for Huntington Disease32 kBanonymousapplication/mswordp01-antisense-oligonucleotide-transcript 
04.08.26Reducing toxic n-terminal Huntingtin fragments in HD using exon skipping32 kBanonymousapplication/mswordp03-exon-skipping 
04.08.26A Huntingtin peptide inhibits polyQ-hHtt associated defects32 kBanonymousapplication/mswordp04-polyq-hhtt-associated-defects 
04.08.26Astrocytes affect neuroprotection: Glatiramer acetate in Huntington`s Disease therapy32 kBanonymousapplication/mswordp07-glatiramer-acetate 
04.08.26Olesoxime improves specific features of the HD pathology32 kBanonymousapplication/mswordp06-olesoxime 
04.08.26Analysis of Nrf2-downstream targets after fumarate treatment in dorsal root ganglia – an anti-inflammatory therapy in neurodegenerative disease?!32 kBanonymousapplication/mswordp08-analysis-of-nrf2 

Verzeichnis enthält 7 Dokumente.
impressum | datenschutz | haftungsausschluss | nutzungsbedingungen